Response to anaplastic lymphoma kinase inhibitor in gastric cancer harboring DCTN1–ALK fusion: a case report and review

Anaplastic lymphoma kinase (ALK) rearrangements are exceedingly rare in gastric cancer, and uncommon fusion types add to the difficulties of proper, precise treatment strategies. Although detected in non-small cell lung cancer (NSCLC), inflammatory myofibroblastic tumors (IMTs), and Spitz tumors, th...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Huadi Wang, Liangkun You, Hong Pan, Xiaotong Qiu, Jin Sheng
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2025-10-01
coleção:	Frontiers in Immunology
Assuntos:	anaplastic lymphoma kinase (ALK) circulating tumor DNA (ctDNA) next generation sequencing (NGS) case report review
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1686666/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!